The trillions of bacteria that reside in the human gut are known to play a critical role in promoting mental and physical health. But new research shows that the gut microbiome can also harbor potential bad actors.
In a study published Oct 27 in the...
A Yale-designed nasal vaccine can help bolster immune responses to COVID-19 in previously vaccinated animals and reduce viral transmission, Yale researchers report Oct. 27 in the journal Science.
The new vaccine approach developed by Yale researchers —...
Our ancestry can be detected not only in our genes, but also in our metabolism, a new Yale-led study has found.
In an analysis of the metabolic profiles of healthy American babies, researchers found surprising differences among ethnic groups, perhaps...
The survival of all animals and insects, from wolves to bees, depends upon their ability to find the source of odors, which is a challenge when wind disperses and obscures their source. Past research has shown that animals and insects navigate their way...
A common feature of autism spectrum disorder, ASD, is reduced eye contact with others in natural conditions. Although eye contact is a critically important part of everyday interactions, scientists have been limited in studying the neurological basis of...
The formation of amyloid plaques in the brain is a hallmark of Alzheimer’s disease. But drugs designed to reduce accumulations of these plaques have so far yielded, at best, mixed results in clinical trials.
Yale researchers have found, however, that...
Since he was a kid Hal Blumenfeld has wondered about the nature of human consciousness.
“It’s what makes us human and makes life worthwhile,” said Blumenfeld, now the Mark Loughridge and Michele Williams Professor of Neurology at Yale. “And it’s still a...
The long-term effects of infection on the immune system have long intrigued John Tsang, a Yale immunobiologist. After the body has faced down a pathogen, does the immune system return to the previous baseline? Or does a single infection change it in ways...
As the COVID-19 pandemic showed, potentially dangerous new viruses can begin to spread in the population well before the global public health surveillance system can detect them.
However, Yale researchers have found that testing for the presence of a...
The investigational drug lecanemab slowed clinical decline in participants with early-stage Alzheimer’s disease by 27% after 18 months of treatment compared with participants who received a placebo, a phase 3 clinical trial has reported.
The results of...